Mallinckrodt Pharmaceuticals Chemical
CEP Certificates (EDQM COS List)
Mallinckrodt Pharmaceuticals Chemical
CEP Database
Certificates of Suitability to the European Pharmacopoeia (CEP), issued by the EDQM.
- Total Records 18
- Latest End Date 2017-10-30
- Data Source EDQM
- Last Updated 2004-11-22
Company Overview
Company
Mallinckrodt Pharmaceuticals Chemical
Country
Ireland
Website
Social Profiles
Company Snapshot
Mallinckrodt Pharmaceuticals Chemical
College Business & Technology Park Cruiserath, Blanchardstown Dublin 15
Ireland
www.mallinckrodt.com/ simon.plevin@mnk.com View on MapCEP Records Timeline (18 records)
Product
Desmopressin
Substance
Mallinckrodt Inc St Louis US
Certificate No.
R0-CEP 2000-060 - Rev 01
Substance No.
712
Issue Date
2004-11-22
End Date
2008-01-31
Country
United States
Identifiers
Certificate No.: R0-CEP 2000-060 - Rev 01
Substance No.: 712
Product
Leuprorelin
Substance
MALLINCKRODT, INC. Hazelwood US
Certificate No.
R1-CEP 2001-323 - Rev 02
Substance No.
1442
Issue Date
2012-07-20
End Date
2017-10-30
Country
United States
Identifiers
Certificate No.: R1-CEP 2001-323 - Rev 02
Substance No.: 1442
Product
Sufentanil
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2019-054 - Rev 01
Substance No.
1569
Issue Date
2026-02-05
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2019-054 - Rev 01
Substance No.: 1569
Product
Buprenorphine, Process II
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2025-111 - Rev 00
Substance No.
1180
Issue Date
2025-11-24
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2025-111 - Rev 00
Substance No.: 1180
Product
Oxycodone hydrochloride
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2021-375 - Rev 01
Substance No.
1793
Issue Date
2025-08-08
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2021-375 - Rev 01
Substance No.: 1793
Product
Naltrexone hydrochloride
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2018-218 - Rev 02
Substance No.
1790
Issue Date
2024-11-20
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2018-218 - Rev 02
Substance No.: 1790
Product
Methylphenidate hydrochloride, Process II, Non-fine (Code 0570) and Fine (Code 1335)
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2020-005 - Rev 01
Substance No.
2235
Issue Date
2024-10-17
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2020-005 - Rev 01
Substance No.: 2235
Product
Sufentanil citrate
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2017-095 - Rev 01
Substance No.
1269
Issue Date
2024-05-06
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2017-095 - Rev 01
Substance No.: 1269
Product
Fentanyl
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2005-260 - Rev 03
Substance No.
1210
Issue Date
2024-02-14
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2005-260 - Rev 03
Substance No.: 1210
Product
Fentanyl citrate
Substance
SPECGX LLC Webster Groves US
Certificate No.
CEP 2009-097 - Rev 02
Substance No.
1103
Issue Date
2024-01-30
End Date
-
Country
United States
Identifiers
Certificate No.: CEP 2009-097 - Rev 02
Substance No.: 1103
Product
Buprenorphine hydrochloride, Process II
Substance
SPECGX LLC Webster Groves US
Certificate No.
R0-CEP 2023-107 - Rev 00
Substance No.
1181
Issue Date
2023-08-24
End Date
-
Country
United States
Identifiers
Certificate No.: R0-CEP 2023-107 - Rev 00
Substance No.: 1181
Product
Naloxone hydrochloride dihydrate, Code 1492
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 2009-294 - Rev 01
Substance No.
729
Issue Date
2023-08-08
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 2009-294 - Rev 01
Substance No.: 729
Product
Dexamfetamine sulfate
Substance
SPECGX LLC Webster Groves US
Certificate No.
R0-CEP 2020-076 - Rev 00
Substance No.
2752
Issue Date
2021-07-26
End Date
-
Country
United States
Identifiers
Certificate No.: R0-CEP 2020-076 - Rev 00
Substance No.: 2752
Product
Buprenorphine
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 2013-098 - Rev 00
Substance No.
1180
Issue Date
2021-06-24
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 2013-098 - Rev 00
Substance No.: 1180
Product
Buprenorphine hydrochloride
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 2013-048 - Rev 00
Substance No.
1181
Issue Date
2021-05-04
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 2013-048 - Rev 00
Substance No.: 1181
Product
Codeine phosphate hemihydrate
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 1999-152 - Rev 04
Substance No.
74
Issue Date
2018-10-04
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 1999-152 - Rev 04
Substance No.: 74
Product
Paracetamol
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 1996-039 - Rev 04
Substance No.
49
Issue Date
2018-04-25
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 1996-039 - Rev 04
Substance No.: 49
Product
Methylphenidate hydrochloride
Substance
SPECGX LLC Webster Groves US
Certificate No.
R1-CEP 2009-140 - Rev 01
Substance No.
2235
Issue Date
2018-02-06
End Date
-
Country
United States
Identifiers
Certificate No.: R1-CEP 2009-140 - Rev 01
Substance No.: 2235
Status Breakdown
18 total- Expired
- Withdrawn by holder
- Valid
Official Source
All data is sourced from the official EDQM CEP database (Certification of Suitability to the European Pharmacopoeia).
Visit EDQMRecord Details Preview
Click "View Details" on any record above to expand full details inline.
Country
United States
Identifiers
Certificate No.: R0-CEP 2000-060 - Rev 01
Substance No.: 712
100% Official Data
Directly from the EDQM CEP database
Regular Updates
Data updated regularly from official sources
Trusted by Professionals
100K+ pharma professionals worldwide
Secure & Reliable
Enterprise-grade security and data protection
Create a New Buying Request
Fields marked with * are mandatory.